The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare ...

MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed ...

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored ...

At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific ...

DUOS, a technology-enabled service provider, has raised $130 million to expand its platform to more health plans across the country, it announced on Thursday. The Minneapolis-based company supports ...

Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...

While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo ...

Digital health funding is holding steady — venture capital is flowing, IPOs are reappearing, and megarounds are back in force. Startups in this space have raised $9.9 billion throughout the first ...

The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at ...

The numbers in drug discovery are daunting. Identifying a molecule with therapeutic promise and advancing it through preclinical and clinical development can take more than a decade at costs topping ...

Healthcare has been moving steadily out of the clinic and into the home. McKinsey estimates that as much as $265 billion in care (nearly a quarter of all Medicare spending) could shift from facilities ...